Optimal Sampling Intervals to Assess Long-Term Glycemic Control Using Continuous Glucose Monitoring-Reference-Cited by-同舟云学术

Optimal Sampling Intervals to Assess Long-Term Glycemic Control Using Continuous Glucose Monitoring

Published:2011-03 Issue:3 Volume:13 Page:351-358
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Xing Dongyuan¹,Kollman Craig¹,Beck Roy W.¹,Tamborlane William V.²,Laffel Lori³,Buckingham Bruce A.⁴,Wilson Darrell M.⁴,Weinzimer Stuart²,Fiallo-Scharer Rosanna⁵,Ruedy for the Juvenile Diabetes Res Katrina J.¹

Affiliation:

1. Jaeb Center for Health Research, Tampa, Florida.

2. Department of Pediatrics, Yale University, New Haven, Connecticut.

3. Joslin Diabetes Center, Boston, Massachusetts.

4. Stanford University, Stanford, California.

5. Barbara Davis Center, Aurora, Colorado.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.liebertpub.com/doi/pdf/10.1089/dia.2010.0156

Reference14 articles.

1. Eight-Point Glucose Testing Versus the Continuous Glucose Monitoring System in Evaluation of Glycemic Control in Type 1 Diabetes

2. Translating the A1C Assay Into Estimated Average Glucose Values

3. Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes

4. Continuous Glucose Monitoring in Youth with Type 1 Diabetes: 12-Month Follow-Up of the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of Glucose Metabolism by Continuous Glucose Monitoring and Validation of Dipeptidyl Peptidase 4 Inhibitor Use in Patients with Myotonic Dystrophy Type 1;Journal of Clinical Medicine;2024-09-05

2. Consequences of Data Loss on Clinical Decision-Making in Continuous Glucose Monitoring: Retrospective Cohort Study;Interactive Journal of Medical Research;2024-07-31

3. Limitations of 14-Day Continuous Glucose Monitoring Sampling for Assessment of Hypoglycemia and Glycemic Variability in Type 1 Diabetes;Diabetes Technology & Therapeutics;2024-07-01

4. Glucose metrics improvement in youths with type 1 diabetes using the Ambulatory Glucose Profile report: A real-world study;Diabetes Research and Clinical Practice;2024-06

5. Continuous Glucose Monitor Metrics Are Associated with Emergency Department Visits and Hospitalizations for Hypoglycemia and Hyperglycemia, but Have Low Predictive Value;Diabetes Technology & Therapeutics;2024-05-01